Total Payments
$10,536
2024 Payments
$228.54
Companies
13
Transactions
41
Medicare Patients
1,490
Medicare Billing
$111,159
Payment Breakdown by Category
Other$5,000 (47.5%)
Consulting$2,450 (23.3%)
Food & Beverage$2,241 (21.3%)
Travel$795.97 (7.6%)
Education$48.95 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,000 | 1 | 47.5% |
| Consulting Fee | $2,450 | 1 | 23.3% |
| Food and Beverage | $2,241 | 35 | 21.3% |
| Travel and Lodging | $795.97 | 3 | 7.6% |
| Education | $48.95 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $5,000 | 1 | $0 (2020) |
| Celgene Corporation | $2,693 | 4 | $0 (2022) |
| ABBVIE INC. | $894.82 | 10 | $0 (2024) |
| Genentech, Inc. | $825.63 | 7 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $450.37 | 10 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $203.18 | 2 | $0 (2019) |
| Allergan Inc. | $165.03 | 1 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $91.76 | 1 | $0 (2021) |
| Takeda Pharmaceuticals America, Inc. | $62.00 | 1 | $0 (2017) |
| NeuroLogica Corporation, a subsidiary of Samsung Electronics Co., Ltd. | $50.00 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $228.54 | 3 | ABBVIE INC. ($149.03) |
| 2023 | $214.57 | 3 | AbbVie Inc. ($115.62) |
| 2022 | $221.88 | 2 | ABBVIE INC. ($125.25) |
| 2021 | $122.46 | 2 | E.R. Squibb & Sons, L.L.C. ($91.76) |
| 2020 | $7,519 | 3 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($5,000) |
| 2019 | $485.84 | 7 | Allergan Inc. ($165.03) |
| 2018 | $1,319 | 16 | Genentech, Inc. ($802.91) |
| 2017 | $424.01 | 5 | AbbVie, Inc. ($362.01) |
All Payment Transactions
41 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $120.98 | General |
| Category: IMMUNOLOGY | ||||||
| 02/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $79.51 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.05 | General |
| Category: IMMUNOLOGY | ||||||
| 04/24/2023 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Education | In-kind items and services | $48.95 | General |
| Category: Immunology | ||||||
| 04/20/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $115.62 | General |
| Category: IMMUNOLOGY | ||||||
| 01/19/2023 | NeuroLogica Corporation, a subsidiary of Samsung Electronics Co., Ltd. | Hera W10 (Device) | Food and Beverage | Cash or cash equivalent | $50.00 | General |
| Category: UltraSound | ||||||
| 05/22/2022 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $96.63 | General |
| 04/21/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $125.25 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2021 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $30.70 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/11/2021 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $91.76 | General |
| Category: Neuroscience | ||||||
| 12/15/2020 | Celgene Corporation | ZEPOSIA (Drug) | Consulting Fee | Cash or cash equivalent | $2,450.00 | General |
| Category: Neuroscience | ||||||
| 02/21/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), UCERIS, RELISTOR | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,000.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/23/2020 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $69.49 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/01/2019 | Genentech, Inc. | Non-Covered Product (Drug) | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: None | ||||||
| 08/02/2019 | Genentech, Inc. | Non-Covered Product (Drug) | Food and Beverage | In-kind items and services | $10.83 | General |
| Category: None | ||||||
| 05/20/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $30.05 | General |
| Category: Immunology | ||||||
| 05/19/2019 | Allergan Inc. | — | Food and Beverage | In-kind items and services | $165.03 | General |
| 05/19/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Entyvio (Biological) | Food and Beverage | In-kind items and services | $33.60 | General |
| Category: Lower GI | ||||||
| 05/18/2019 | Janssen Scientific Affairs, LLC | STELARA (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Immunology | ||||||
| 01/26/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Entyvio (Biological) | Food and Beverage | In-kind items and services | $109.44 | General |
| Category: Lower GI | ||||||
| 08/21/2018 | Janssen Scientific Affairs, LLC | STELARA (Biological) | Food and Beverage | In-kind items and services | $78.18 | General |
| Category: Immunology | ||||||
| 06/03/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Entyvio (Biological) | Food and Beverage | In-kind items and services | $26.23 | General |
| Category: Lower GI | ||||||
| 05/31/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $112.86 | General |
| Category: Immunology | ||||||
| 05/04/2018 | Genentech, Inc. | — | Food and Beverage | In-kind items and services | $4.11 | General |
| 05/03/2018 | Genentech, Inc. | — | Travel and Lodging | In-kind items and services | $538.63 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 392 | 417 | $309,003 | $29,506 |
| 2022 | 8 | 380 | 421 | $267,385 | $28,699 |
| 2021 | 9 | 436 | 476 | $324,276 | $32,511 |
| 2020 | 8 | 282 | 303 | $187,419 | $20,442 |
Total Patients
1,490
Total Services
1,617
Medicare Billing
$111,159
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 36 | 36 | $66,285 | $7,021 | 10.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2023 | 21 | 21 | $37,976 | $4,028 | 10.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 36 | 37 | $57,552 | $2,980 | 5.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 29 | 36 | $8,530 | $2,428 | 28.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 17 | $7,757 | $2,308 | 29.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 14 | 24 | $5,667 | $2,236 | 39.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 25 | 25 | $27,974 | $2,090 | 7.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2023 | 23 | 23 | $35,511 | $1,901 | 5.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2023 | 19 | 19 | $21,260 | $1,519 | 7.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 18 | 19 | $4,437 | $1,371 | 30.9% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 13 | 13 | $12,607 | $1,047 | 8.3% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 74 | 79 | $12,601 | $311.27 | 2.5% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Office | 2023 | 67 | 68 | $10,846 | $266.65 | 2.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 33 | 58 | $12,687 | $4,607 | 36.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 25 | 25 | $10,674 | $3,700 | 34.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 18 | 19 | $36,595 | $3,585 | 9.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2022 | 32 | 33 | $50,818 | $3,299 | 6.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 32 | 32 | $49,899 | $3,047 | 6.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2022 | 14 | 14 | $25,547 | $2,777 | 10.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 27 | 31 | $6,856 | $1,958 | 28.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 26 | 26 | $29,092 | $1,954 | 6.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 20 | 23 | $5,110 | $1,689 | 33.1% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 18 | 18 | $17,456 | $1,534 | 8.8% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2022 | 86 | 91 | $14,515 | $361.98 | 2.5% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Office | 2022 | 49 | 51 | $8,135 | $186.97 | 2.3% |
About Dr. John Valentine, MD
Dr. John Valentine, MD is a Gastroenterology healthcare provider based in Salt Lake City, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1144263419.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Valentine, MD has received a total of $10,536 in payments from pharmaceutical and medical device companies, with $228.54 received in 2024. These payments were reported across 41 transactions from 13 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($5,000).
As a Medicare-enrolled provider, Valentine has provided services to 1,490 Medicare beneficiaries, totaling 1,617 services with total Medicare billing of $111,159. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Salt Lake City, UT
- Active Since 06/14/2006
- Last Updated 12/20/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1144263419
Products in Payments
- XIFAXAN (Drug) $5,000
- ZEPOSIA (Drug) $2,542
- Humira (Biological) $406.25
- SKYRIZI (Biological) $264.65
- STELARA (Biological) $203.18
- ENTYVIO (Biological) $179.70
- Entyvio (Biological) $169.27
- RINVOQ (Biological) $125.25
- Edarbyclor (Drug) $62.00
- Hera W10 (Device) $50.00
- TREMFYA (Drug) $48.95
- Non-Covered Product (Drug) $22.72
- Alinia Tablets 500mg 30 count bottle (Drug) $17.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Salt Lake City
Richard Gilroy, Md, MD
Gastroenterology — Payments: $252,278
Gastroenterology $252,278
Kathryn Peterson, Md, MD
Gastroenterology — Payments: $94,047
Gastroenterology $94,047
Dr. Peder Pedersen, M.d, M.D
Gastroenterology — Payments: $67,521
Gastroenterology $67,521
Amir Kashani
Gastroenterology — Payments: $43,637
Gastroenterology $43,637
Dr. Juan Gallegos-Orozco, M.d, M.D
Gastroenterology — Payments: $30,877
Gastroenterology $30,877
Iqbal Sandhu, Md, MD
Gastroenterology — Payments: $18,270
Gastroenterology $18,270